Black Willow (Nelco Laboratories, Inc.)


Welcome to the PulseAid listing for the Black Willow drug offered from Nelco Laboratories, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Nelco Laboratories, Inc.
NON-PROPRIETARY NAME: Black Willow
SUBSTANCE NAME: SALIX NIGRA POLLEN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRADERMAL; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1972-08-29
END MARKETING DATE: 0000-00-00


Black Willow HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBlack Willow from Nelco Laboratories, Inc.
LABELER NAME: Nelco Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10000([PNU]/mL)
START MARKETING DATE: 1972-08-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 36987-3085_0d62fd2a-d535-41ba-b17b-cf1e1f8b216b
PRODUCT NDC: 36987-3085
APPLICATION NUMBER: BLA102192

Other SALIX NIGRA POLLEN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
ALK-Abello, Inc.SALIX NIGRA POLLEN
Allergy Laboratories, Inc.BLACK WILLOW POLLEN
Allermed Laboratories, Inc.Black Willow Pollen
Antigen Laboratories, Inc.Black Willow
Jubilant HollisterStier LLCPollens – Trees, Willow, Black Salix nigra
Nelco Laboratories, Inc.Black Willow